1. Home
  2. OM vs INCR Comparison

OM vs INCR Comparison

Compare OM & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Outset Medical Inc.

OM

Outset Medical Inc.

HOLD

Current Price

$2.82

Market Cap

59.2M

Sector

Health Care

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

SELL

Current Price

$3.28

Market Cap

58.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OM
INCR
Founded
2003
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.2M
58.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
OM
INCR
Price
$2.82
$3.28
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $7.67
N/A
AVG Volume (30 Days)
★ 82.8K
9.8K
Earning Date
11-04-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $119,476,000.00
N/A
Revenue This Year
$6.72
$222.95
Revenue Next Year
$9.25
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 5.09
N/A
52 Week Low
$2.84
$0.68
52 Week High
$6.49
$6.10

Technical Indicators

Market Signals
Indicator
OM
INCR
Relative Strength Index (RSI) 27.40 32.01
Support Level N/A $3.12
Resistance Level $3.31 $4.19
Average True Range (ATR) 0.30 0.25
MACD -0.16 -0.01
Stochastic Oscillator 3.47 15.00

Price Performance

Historical Comparison
OM
INCR

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: